Bristol Myers Squibb Stocks List Ranked for 2024 |

Symbol	Grade	Name	% Change
CTMX	C	CytomX Therapeutics, Inc.	-0.85
TSVT	D	2seventy bio, Inc.	-8.30
SNY	D	Sanofi	-1.56
RAPT	F	RAPT Therapeutics, Inc.	-2.18
BMY	F	Bristol-Myers Squibb Company	1.07

Related Industries: Biotechnology Drug Manufacturers - Major

Symbol	Grade	Name	Weight
PPH	C	Market Vectors Pharmaceutical ETF	8.9
FTXH	D	First Trust Nasdaq Pharmaceuticals ETF	7.23
MEDX	F	Horizon Kinetics Medical ETF	5.43
IHE	C	iShares U.S. Pharmaceutical ETF	4.4
CNCR	D	Loncar Cancer Immunotherapy ETF	4.31

Compare ETFs

Compare FTXH to CNCR Compare PPH to CNCR Compare PPH to FTXH

Date	Stock	Title
Apr 18	BMY	Earnings Preview: Bristol Myers Squibb (BMY) Q1 Earnings Expected to Decline
Apr 17	BMY	Bristol-Myers Squibb: Market Pessimism Won't Last Forever
Apr 17	BMY	2 High-Yield Dividend Stocks to Buy and Hold for 10 Years
Apr 17	SNY	IGM Biosciences announces refocusing of Sanofi collaboration
Apr 17	SNY	Press Release: New 48-week frexalimab phase 2 data support potential for high sustained efficacy in multiple sclerosis
Apr 15	BMY	Bristol Myers Squibb (BMY) Advances While Market Declines: Some Information for Investors
Apr 15	BMY	In the wake of Bristol-Myers Squibb Company's (NYSE:BMY) latest US$5.7b market cap drop, institutional owners may be forced to take severe actions
Apr 15	BMY	Better Buy: Bristol Myers Squibb or the Vanguard S&P 500 ETF?
Apr 12	SNY	Sanofi: Information concerning the total number of voting rights and shares - March 2024
Apr 12	BMY	Bristol Myers Squibb: Seriously Undervalued At Peak Pessimism (Rating Upgrade)
Apr 12	BMY	The Zacks Analyst Blog Highlights Bristol Myers, Moderna, 2seventy bio, Amylyx Pharmaceuticals and Syros Pharmaceuticals
Apr 12	BMY	Wall Street Favorites: 3 Warren Buffett Stocks With Strong Buy Ratings for April 2024

Bristol Myers Squibb: Bristol-Myers Squibb Company (BMS) is an American pharmaceutical company, headquartered in New York City.
Bristol-Myers Squibb manufactures prescription pharmaceuticals and biologics in several therapeutic areas, including cancer, HIV/AIDS, cardiovascular disease, diabetes, hepatitis, rheumatoid arthritis and psychiatric disorders.
BMS' primary R&D sites are located in Lawrence, New Jersey (formerly Squibb, near Princeton) and Wallingford, Connecticut (formerly Bristol-Myers); with other sites in East Syracuse, New York; Princeton Pike, Hopewell Township and New Brunswick, New Jersey; and in Swords, Ireland; Braine-l'Alleud, Belgium; Tokyo, Japan; and Bangalore, India.